Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "MammaPrint Index as a Predictive Biomarker for Neoadjuvant Chemo Response & Outcome in Patients With HR+/HER2- BC in NBRST"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
William Audeh
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
William Audeh
239 views
June 14, 2023
Comments 0
Login to view comments.
Click here to Login
Breast